Phoremost
PrivateLast Round
Series B
Extension
Sep 10, 2024
Total Funding Raised
$76.8M
Momentum Score
25 /100
Company Overview
PhoreMost is a biotechnology company specializing in drug target identification and discovery services that leverage cryptic druggable sites in the human genome to inform the design of innovative small molecule drugs for therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phoremost Comps
Public and private peers based on sector, stage, and business model.
Phoremost Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 10, 2024 | ||||
| Series B | Mar 23, 2021 | ||||
| Series A | May 15, 2018 | ||||
| Seed | Apr 8, 2015 |
Key People
Founding team and executive leadership
Phoremost Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series A, Series B Extension |
| BGF | Series B Extension, Series B |
| o2h ventures | Series B |
| Morningside Ventures | Series A, Series B |
| Cambridge Enterprise | Series A, Seed |
| Astellas Venture Management | Series B Extension, Series B |
| Trend Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2025
Dr. Adam Gilbert joins the Scientific Advisory Board.
- May 7, 2025
Stephen Dilly joins as Non-Executive Director.
Phoremost Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phoremost's valuation, stock price, and market status.
